Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

ALOM Goals to Lower Greenhouse Gas Emissions Validated by Science Based Targets initiative (SBTi)


SBTi is a collaboration among the United Nations Global Compact (UNGC), World Resources Institute (WRI), the CDP, a nonprofit helping entities disclosing environmental impact, the World Wide Fund for Nature, (WWF) and one of the We Mean Business Coalition commitments. SBTi defines and promotes best practice in science-based target setting, offers resources and guidance to reduce barriers to adoption, and independently assesses and approves companies’ targets.

“As a company that has long been committed to a healthier planet, we take our role as a leader in reducing emissions in the supply chain as profoundly important for our economic and environmental well-being,” added Hannah Kain, President and CEO of ALOM. “Given that close to 90% of GHG emissions result from supply chains serving companies that produce and ship physical goods, we believe our industry has an opportunity – and a responsibility – to act decisively with SBTi targets in mind.”

In line with SBTi criteria to limit the global temperature rise, ALOM is prioritizing direct emissions reductions and neutralizing all residual emissions. This verification is one of ALOM’s science-based milestones of rigorous certifications, best-in-class partnerships, and innovative programs to monitor and report GHG reduction.

For example, ALOM’s ISO 14064-1 certification ensures transparency in tracking and reporting all direct and indirect scope 1, 2, and 3 GHG emissions. As a Green Power Partner with the U.S. Environmental Protection Agency (EPA), ALOM must verify its ongoing use and GHG reduction impact of clean energy use.

Further initiatives enacted by ALOM to achieve its SBTi verified GHG reduction targets include:

  •     Nearsource its supply base to reduce freight transport distance
  •     Execute meaningful sustainable procurement and packaging strategies
  •     Support aggressive recycling and reuse programs
  •     Implement energy-saving technology

ALOM works collaboratively with customers and suppliers to extend the scale of its GHG emission reduction initiatives. The company can provide GHG data specific to the delivery of customer programs to quantify its contribution to achieving customers’ own GHG reduction goals. Across its supply base, ALOM partners with suppliers that support its environmental values and have enacted greenhouse gas reduction and measurement initiatives – or are in the process of doing so.

SBTi target verification is an important milestone for ALOM in meeting its GHG emission reduction goals. Read about the company’s ESG commitment and download its 2023 ESG report: https://alom.com/esg-centric-values/

To learn more about Science Based Targets initiative, visit https://sciencebasedtargets.org/

About ALOM
ALOM is a global supply chain management services and solutions provider, serving as a strategic partner to its Fortune 500 clients in the technology, automotive, life sciences, and highly regulated industry sectors. Headquartered in Fremont, CA, USA, its teams of technology engineers and supply chain specialists operate globally from 19 locations.

Committed to environmental and social responsibility, ALOM manages the physical supply chain from procurement, inventory management, contract assembly, digital media and print, to omni-channel fulfillment and returns. ALOM seamlessly integrates digital and financial streams into the physical supply chain, deploying e-commerce and payment solutions, visibility tools, digital delivery tools, data management, and strong back-end systems, all while producing and fulfilling goods worldwide.

ALOM is proud to deliver its clients’ products and services impeccably, enrich the end-user experience, and uphold their brand reputations. https://alom.com/

Media Contact

Lynthia Romney, ALOM, (914) 589-2140, [email protected], www.alom.com 

Paul Hendrycks, ALOM, (510) 360-3628, [email protected], www.alom.com 

SOURCE ALOM

Assistant Secretary for Health Admiral Rachel L. Levine, M.D., Dr. Chelsea Clinton, Kohl’s, to Speak at 2023 America’s Healthiest Schools Leaders Summit, October 13-14


School representatives to be recognized in Washington, D.C. for extraordinary contributions to student, staff, and family health

NEW YORK, Oct. 10, 2023 /PRNewswire-PRWeb/ — Today, Alliance for a Healthier Generation, the nation’s preeminent children’s health organization, announced details for the upcoming annual America’s Healthiest Schools Leaders Summit (Leaders Summit) to be held on October 13-14 in Washington, D.C. The event will begin with a land acknowledgement led by Kelley Klor, a citizen of Cherokee Nation who also works for the Association of Tribal Archives, Libraries, and Museums, as well as opening remarks from Dr. Chelsea Clinton and American Heart Association CEO Nancy Brown on the critical role of educators and school staff as agents of change and impact in equitable whole child health. Programming will include fireside chats and community discussions on strategies to promote youth mental wellness and resiliency; building school-community collaborations for collective impact; and the intersectionality of technology, belonging, connection, and innovation.

In addition, as part of the program Healthier Generation will showcase the important role corporations play in improving the lives of our nation’s children by presenting the Healthier Generation Corporate Hero Award. At this year’s Leaders Summit, Kohl’s will be honored as the 2023 Healthier Generation Corporate Hero for its service and commitment to children’s health and specifically for its cornerstone collaboration with Healthier Generation, “Kohl’s Healthy at Home,” which has impacted eight million families since its inception in 2019.

The Leaders Summit will host hundreds of representatives from schools across the country who were instrumental in distinguishing their campus among the 2023 America’s Healthiest Schools, Healthier Generation’s annual recognition program that honors schools for adopting best practices to advance the physical, mental, and social-emotional health of their staff and students. School attendees represent the most-recognized awardees in four or more topic areas of the prestigious award program.

Participants in past Leaders Summits include President William J. Clinton, Senator Cory Booker, Kevin Concannon (U.S. Dept. of Agriculture), Charles Milam (U.S. Dept. of Defense), Michelle Kwan (U.S Ambassador to Belize) and Nike (previous Corporate Hero Awardee).

Sponsors for the 2023 America’s Healthiest Schools Leaders Summit include Harmony SEL at National University, Kaiser Permanente, and Kohl’s.

Media registration is now open. Register* at http://www.ahsleaderssummit.org with the promo code: LS23REG. *Select “Press” for registration type.

More information about the America’s Healthiest Schools Leaders Summit is available at https://www.ahsleaderssummit.org/.

About Alliance for a Healthier Generation

Alliance for a Healthier Generation is a leading children’s health organization that advances equitable whole child health. Driven by our passion to ensure that every mind, every body, and every young person is healthy and ready to succeed, our work has reached over 31 million young people and 54,000 schools across the country. To learn more and help make a difference, visit HealthierGeneration.org and join us on FacebookTwitter, and Instagram.

Media Contact

Audrey Rodriguez, Alliance for a Healthier Generation, 512-368-0924, [email protected], https://www.healthiergeneration.org/

Twitter

SOURCE Alliance for a Healthier Generation



Recent FDA/EMA Updates, Upcoming Webinar Hosted by Xtalks


Although the scenarios for embedding labeling studies in the clinical development program may depend on prioritization, budgets and sheer practicalities, drug development usually benefits from setting up a well-balanced strategy early on during drug development.

Over the past three years, the Food and Drug Administration (FDA) and/or European Medicines Agency (EMA) have issued either final guidance or updated guidelines for food effect, DDI, ADME, TQT and renal impairment studies. This webinar will summarize these key guidance documents and highlight recent changes drug developers need to know.

From the perspective of current regulatory guidance, this webinar will consider the setup and conduct of selected labeling studies, strategic aspects and best practices.

Join this webinar to gain insights into the latest guidelines from the FDA and EMA on drug labeling in clinical pharmacology.

Join experts from Celerion, Aernout van Haarst, PhD, Director of Scientific Affairs; and Sabina Paglialunga, PhD, Director of Scientific Affairs, for the live webinar on Tuesday, October 24, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Drug Labeling Studies in Clinical Pharmacology: Recent FDA/EMA Updates.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

How to Co-Design Your Solution with Patients, Upcoming Webinar Hosted by Xtalks


In this webinar, the featured speakers will discuss key patient-relevant features to be included in this approach. They will also review the ways to define patient experience expectations to help increase patient preferences, how to generate evidence to support usability and safe use claims in regulatory processes and how to determine relevant patient key performance indicators (KPIs) to measure the solutions’ potential market fit.

Join Alira Health‘s patient engagement experts for a deep dive into patient centric co-design. Discover the key elements of a validated and measurable methodology that can help healthcare providers to solve patients’ unmet needs.

Join Raquel Navarro, Insights Manager, Roche Diabetes Care; Giulia Pierini, Associate Director, Consulting Patient Engagement, Alira Health; and Eduardo Perez-Guagnelli, Patient-Centric Co-Design Lead, Alira Health, for the live webinar on Monday, October 23, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit How to Co-Design Your Solution With Patients.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Managing Critical Lab Materials through Connected Digital Solutions, Upcoming Webinar Hosted by Xtalks


The current generation of scientists entering the labs are accustomed to the daily use of digital connectivity tools, such as video calling and smartphones, and will expect the same kinds of tools will be at their disposal for lab inventory management decision-making. End users are expecting connectivity for the sole purpose of providing information or the ability to act. A connected lab where the scientist can source directly from their application of choice (i.e., ELN, LIMS) and get visibility into stock levels at any given moment is becoming more and more the reality. With the right materials and tools on hand when needed, Scientists can manage their research and development (R&D) workflows more efficiently and accurately. This will drive more efficient/effective processes in the lab and ultimately lead to productivity gains, moving science forward.

Register for this webinar to learn more about digital solutions that can help mitigate the challenges of modern-day lab inventory management to optimize and scale lab operations, allowing you to reclaim time for science.

Join Jim Rubbo, Director, Digital Services Portfolio, Avantor, for the live webinar on Tuesday, October 24, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Managing Critical Lab Materials through Connected Digital Solutions.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Medical Office Building M&A Activity Decreases 23% in Q3:23, According to Data from LevinPro HC


Announced spending in the third quarter decreased by approximately 49% from $380.6 million in Q2:23 to $194.7 million in Q3:23. The largest MOB deal by disclosed price was Sila Realty Trust’s acquisition of a 104,912-square-foot MOB in Burr Ridge, Illinois for $59.95 million.

In Q3:23, a few select states saw a significant concentration of M&A activity in the MOB sector, as per data collected by LevinPro HC. Among these states, Tennessee recorded the highest number of transactions with six deals, accounting for 13.6% of the total. Following close behind was Arizona with four deals and New York with three.

The busiest acquirer in the MOB market during Q3:23 was Montecito Medical Real Estate, with 10 deals, encompassing 162,780 square feet across the United States. Montecito Medical’s largest transaction of the quarter was the acquisition of a 21,000-square-foot MOB in Bartlett, Tennessee, for $48 million. The second busiest acquirer in the MOB sector was a joint venture between Sendero Capital and Angelo Gordon & Company, with three acquisitions. Additionally, Harrison Street and Four Corners Property Trust each announced two transactions during the quarter.

“Right now, there is a lot of uncertainty surrounding the healthcare real estate and lending market in 2024,” continued Swett. “Much of its future performance will depend on the Federal Reserve and how it handles the eventual decline in interest rates.”

Check out our most recent whitepaper here, written by Healthcare Editor Dylan Sammut, to learn more about recent trends in the healthcare real estate and lending market.

All quarterly results are published in The Health Care M&A Report for all 13 sectors of health care, which is part of LevinPro HC. For information, or to order the reports, call 800-248-1668. Irving Levin Associates is celebrating more than 70 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has offices in New Canaan, Connecticut, and North Bethesda, Maryland. The company publishes research reports and newsletters and maintains databases on the healthcare and senior housing M&A markets.

Media Contact

Dylan Sammut, Irving Levin Associates, 203-846-6800, [email protected], www.levinassociates.com

SOURCE Irving Levin Associates

RevSpring Reveals Engage IQ™ Enhancements Focused on Patient Understanding and Trust at HLTH 2023


Welcome Cards: Building trust with patients is critical for them to receive and act on important healthcare information. Engage IQ Welcome Cards™ deliver branded and engaging contact information via text messaging, so patients can easily store it on their mobile devices and trust subsequent messages from the provider.

“Welcome Cards are designed to reduce provider opt-out rates by building patient understanding and trust,” said RevSpring CEO Scott MacKenzie. “Subsequent messages delivered from the same number are now from a known contact, and clearly branded on receipt so every text message from the provider is more likely to be effective.”

Image View: RevSpring patient communications and statements use design theory and AI to ensure that critical information is read within the first 2 seconds of viewing, so patients are more likely to take the right action.

With Engage IQ Image View™, the same effective use of graphics is now available in email and text communications sent to patients. Image View embeds graphical images into texts and emails to convey important information to patients faster. Product images, provider branding, sponsored content, and even fully-composed letters and statements can be delivered within a text or email in a HIPPA compliant manner.

“90% of consumers say that images help them to better understand the content of a text message,” said Kristen Jacobsen, VP of omnichannel engagement and marketing at RevSpring. “We’re bringing the same proven communications strategies that agencies and leading brands use effectively in consumer communications, to healthcare.”

Message Board: RevSpring’s new digital Message Boards provide dynamic messaging for patients, both on their mobile device or in the facility. Engage IQ Message Boards™ inform patients of their place in line for services, integrated with RevSpring’s popular Arrived™ solution for patient check-in.

Insights and Optimizations: Initially announced at HIMSS, RevSpring’s Insights and Optimizations™ uses AI to discover engagement strategies that will improve patient response and outcomes. Using RevSpring’s OmniBrain™ patient journey analytics platform, Insights and Optimizations precisely identifies the key characteristics of top and bottom responders (i.e. patients who make a payment) through data patterning and AI, and will now recommend up to 10 areas of improvement for better engagement outcomes.

Engage IQ is built to ensure the best response and outcomes at each stage of the patient journey. It is also designed to make the overall experience remarkable, by building trust with patients through consistency and personalization.

“The enhancements to Engage IQ that we are announcing today are designed to minimize patient effort and inspire action for engagement applications such as form completion, payments, appointment setting, survey response and more,” added MacKenzie. “RevSpring strives to apply the most effective communications strategies to help providers and payers build stronger, more effortless, and ultimately more lasting relationships with their patients.”

RevSpring will be showcasing the Engage IQ™ patient experience at HLTH 2023, booth V-6518.

About RevSpring
RevSpring leads the market in engagement and payment solutions that inspire patients to participate in and pay for their healthcare. The company has built the industry’s most comprehensive and impactful patient engagement suite, spanning the clinical, administrative and financial experience. RevSpring’s OmniChannel communications and payment solutions are backed by behavior analysis, propensity-to-pay scoring, contextual messaging, and user experience best practices. Using proprietary data analytics to tailor the engagement from preservice to post-service to payment, RevSpring improves the patient experience and outcomes for providers, members and patients. To learn more, visit revspringinc.com/healthcare. Follow us on LinkedIn and X (formerly Twitter). 

Media Contact

Kristen Jacobsen, RevSpring, 7639235280, [email protected], www.revspringinc.com

Kellie Kennedy, The Harbinger Group, 3129334903, [email protected], www.theharbingergroup.com

SOURCE RevSpring



Crunch Fitness Franchisee CR Fitness Expands into Texas with Grand Opening of Crunch Plano


“We are excited to introduce the unique Crunch experience to the residents of Plano and the neighboring communities,” said Tony Scrimale, CEO of CR Fitness. “We can’t wait to showcase how we combine top-tier equipment, exceptional classes, and personal training at an unbeatable value.”

Fusing fitness with entertainment, Crunch Plano boasts top-quality strength training equipment, an extensive selection of premier cardio equipment, a Group Fitness Studio, HIITZone™, a Cycling Studio, Cryotherapy, Dry Saunas, HydroMassage®, tanning facilities, and spacious locker rooms, among other amenities.

CR Fitness Holdings is led by a group of seasoned fitness industry veterans: Vince Julian, Geoff Dyer, Jeff Dotson, and Tony Scrimale, whose collective expertise surpasses 150 years. At present, the CR Fitness team operates 55 Crunch Fitness locations, covering regions in Florida, Georgia, North Carolina, and Texas. The forthcoming debut of Crunch Plano as the 56th location marks another milestone in their expansion across Texas, complementing CR Fitness’ existing Crunch locations in Frisco and Arlington. Additionally, they have announced the upcoming openings of Crunch Allen and Crunch North Richland Hills, formerly UFC gyms, both set to open their doors in late December, further solidifying their presence in the State of Texas.

To kickstart the festivities and provide our community with a preview of what awaits, Crunch Plano will host a “Sneak Peek Sip Sip” event on Thursday, October 12, from 6 p.m. to 9 p.m. Everyone is invited to join in the festivities and embark on their journey towards a healthier, happier lifestyle.

Media Contact

Tricia Mason, CR Fitness Holdings, LLC., 8136017471, [email protected], crunch.com

SOURCE CR Fitness Holdings, LLC.

U.S. Drug Distribution Industry Gaining from Anti-Obesity Drugs and Provider-Administered Biosimilars


This unique, encyclopedic resource analyzes the crucial healthcare trends that will affect wholesale distribution of prescription pharmaceuticals. Now in its 14th edition, The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors offers 163 proprietary charts, exhibits, and data tables. It remains the most comprehensive resource for analyzing the pharmaceutical distribution industry’s economics, market structure, growth rates, forces of change, and interactions within the U.S. healthcare system. The new report also provides an updated analysis of each of the Big Three public companies’ business segments and underlying profitability, based upon DCI’s proprietary economic models.

“Biosimilars of provider-administered specialty drugs are now an important source of profits for wholesalers and specialty distributors,” Fein adds. “The biosimilar market has continued to expand as adoption grows, prices decline, and payers relax formulary limits.”

To purchase and immediately download the new report, visit https://drugch.nl/wholesale. To read a free report overview, visit https://drugch.nl/overview-2023-24

About Drug Channels Institute

Drug Channels Institute is a leading source of industry research about pharmaceutical economics and the drug distribution system. To learn more about its products, visit www.drugchannelsinstitute.com. Access Dr. Fein’s popular Drug Channels blog at www.drugchannels.net.

Media Contact

Tamra Feldman, Drug Channels Institute, 1 2155235700, [email protected]www.drugchannelsinstitute.com

SOURCE Drug Channels Institute